{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:35:19Z","timestamp":1780965319183,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11102-022-01250-y","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T17:02:36Z","timestamp":1658163756000},"page":"819-830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Giant prolactinoma in children and adolescents: a single-center experience and systematic review"],"prefix":"10.1007","volume":"25","author":[{"given":"Sandeep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Sarathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag Ranjan","family":"Lila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeetkaur","family":"Sehemby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba Samad","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjiri","family":"Karlekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Sankhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra A.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"1250_CR1","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab 33:101290. https:\/\/doi.org\/10.1016\/j.beem.2019.101290","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1250_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00431-017-3042-5","volume":"177","author":"A Hoffmann","year":"2018","unstructured":"Hoffmann A, Adelmann S, Lohle K et al (2018) Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis. Eur J Pediatr 177:125\u2013132. https:\/\/doi.org\/10.1007\/s00431-017-3042-5","journal-title":"Eur J Pediatr"},{"key":"1250_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/cen.14394","volume":"94","author":"VB Arya","year":"2021","unstructured":"Arya VB, Aylwin SJB, Hulse T et al (2021) Prolactinoma in childhood and adolescence-Tumour size at presentation predicts management strategy: single centre series and a systematic review and meta-analysis. Clin Endocrinol (Oxf) 94:413\u2013423. https:\/\/doi.org\/10.1111\/cen.14394","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1250_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000495184","volume":"109","author":"I Shimon","year":"2019","unstructured":"Shimon I (2019) Giant prolactinomas. Neuroendocrinology 109:51\u201356. https:\/\/doi.org\/10.1159\/000495184","journal-title":"Neuroendocrinology"},{"key":"1250_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01184-x","author":"A Alikasifoglu","year":"2021","unstructured":"Alikasifoglu A, Celik NB, Ozon ZA et al (2021) Management of prolactinomas in children and adolescents; which factors define the response to treatment? Pituitary. https:\/\/doi.org\/10.1007\/s11102-021-01184-x","journal-title":"Pituitary"},{"key":"1250_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/cen.12242","volume":"79","author":"AB Moraes","year":"2013","unstructured":"Moraes AB, dos Silva CM, S, Vieira Neto L, Gadelha MR, (2013) Giant prolactinomas: the therapeutic approach. Clin Endocrinol (Oxf) 79:447\u2013456. https:\/\/doi.org\/10.1111\/cen.12242","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1250_CR7","first-page":"989","volume":"87","author":"G Di Chiro","year":"1962","unstructured":"Di Chiro G, Nelson KB (1962) The volume of the sella turcica. Am J Roentgenol Radium Ther Nucl Med 87:989\u20131008","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"1250_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/2230-8210.159028","volume":"19","author":"VV Khadilkar","year":"2015","unstructured":"Khadilkar VV, Khadilkar AV (2015) Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5\u201318-year-old Indian children. Indian J Endocrinol Metab 19:470\u2013476. https:\/\/doi.org\/10.4103\/2230-8210.159028","journal-title":"Indian J Endocrinol Metab"},{"key":"1250_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000486840","volume":"12","author":"F Fanelli","year":"2018","unstructured":"Fanelli F, Baronio F, Ortolano R et al (2018) Normative basal values of hormones and proteins of gonadal and adrenal functions from birth to adulthood. Sex Dev 12:50\u201394. https:\/\/doi.org\/10.1159\/000486840","journal-title":"Sex Dev"},{"key":"1250_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-020-01516-x","volume":"18","author":"AS Pe\u00f1a","year":"2020","unstructured":"Pe\u00f1a AS, Witchel SF, Hoeger KM et al (2020) Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med 18:72. https:\/\/doi.org\/10.1186\/s12916-020-01516-x","journal-title":"BMC Med"},{"key":"1250_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1530\/EC-15-0105","volume":"5","author":"S Khare","year":"2016","unstructured":"Khare S, Lila AR, Patt H et al (2016) Gender differences in macroprolactinomas: a single centre experience. Endocr Connect 5:20\u201327. https:\/\/doi.org\/10.1530\/EC-15-0105","journal-title":"Endocr Connect"},{"key":"1250_CR12","doi-asserted-by":"publisher","first-page":"R213","DOI":"10.1530\/EJE-14-0013","volume":"170","author":"D Maiter","year":"2014","unstructured":"Maiter D, Delgrange E (2014) Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur J Endocrinol 170:R213-227. https:\/\/doi.org\/10.1530\/EJE-14-0013","journal-title":"Eur J Endocrinol"},{"key":"1250_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1210\/jc.2014-3670","volume":"100","author":"S Salenave","year":"2015","unstructured":"Salenave S, Ancelle D, Bahougne T et al (2015) Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. J Clin Endocrinol Metab 100:1177\u20131186. https:\/\/doi.org\/10.1210\/jc.2014-3670","journal-title":"J Clin Endocrinol Metab"},{"key":"1250_CR14","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1210\/jcem.82.7.4088","volume":"82","author":"E Delgrange","year":"1997","unstructured":"Delgrange E, Trouillas J, Maiter D et al (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102\u20132107. https:\/\/doi.org\/10.1210\/jcem.82.7.4088","journal-title":"J Clin Endocrinol Metab"},{"key":"1250_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-13-0503","volume":"170","author":"E Delgrange","year":"2014","unstructured":"Delgrange E, Raverot G, Bex M et al (2014) Giant prolactinomas in women. Eur J Endocrinol 170:31\u201338. https:\/\/doi.org\/10.1530\/EJE-13-0503","journal-title":"Eur J Endocrinol"},{"key":"1250_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2265.1989.tb03734.x","volume":"30","author":"TA Howlett","year":"1989","unstructured":"Howlett TA, Wass JA, Grossman A et al (1989) Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy. Clin Endocrinol (Oxf) 30:131\u2013140. https:\/\/doi.org\/10.1111\/j.1365-2265.1989.tb03734.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1250_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fendo.2020.00527","volume":"11","author":"A Yang","year":"2020","unstructured":"Yang A, Cho SY, Park H et al (2020) Clinical, hormonal, and neuroradiological characteristics and therapeutic outcomes of prolactinomas in children and adolescents at a single center. Front Endocrinol (Lausanne) 11:527. https:\/\/doi.org\/10.3389\/fendo.2020.00527","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1250_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11102-008-0149-8","volume":"12","author":"SV Acharya","year":"2009","unstructured":"Acharya SV, Gopal RA, Bandgar TR et al (2009) Clinical profile and long term follow up of children and adolescents with prolactinomas. Pituitary 12:186\u2013189. https:\/\/doi.org\/10.1007\/s11102-008-0149-8","journal-title":"Pituitary"},{"key":"1250_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1507\/endocrj.EJ17-0268","volume":"65","author":"Y-M Kim","year":"2018","unstructured":"Kim Y-M, Seo GH, Kim Y-M et al (2018) Broad clinical spectrum and diverse outcomes of prolactinoma with pediatric onset: medication-resistant and recurrent cases. Endocr J 65:307\u2013315. https:\/\/doi.org\/10.1507\/endocrj.EJ17-0268","journal-title":"Endocr J"},{"key":"1250_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-12114-7_1","volume":"846","author":"N Ben-Jonathan","year":"2015","unstructured":"Ben-Jonathan N, Hugo E (2015) Prolactin (PRL) in adipose tissue: regulation and functions. Adv Exp Med Biol 846:1\u201335. https:\/\/doi.org\/10.1007\/978-3-319-12114-7_1","journal-title":"Adv Exp Med Biol"},{"key":"1250_CR21","doi-asserted-by":"publisher","first-page":"e12702","DOI":"10.1111\/jne.12702","volume":"31","author":"RA Augustine","year":"2019","unstructured":"Augustine RA, Knowles PJ, Khant Aung Z et al (2019) Impaired hypothalamic leptin sensitivity in pseudopregnant rats treated with chronic prolactin to mimic pregnancy. J Neuroendocrinol 31:e12702. https:\/\/doi.org\/10.1111\/jne.12702","journal-title":"J Neuroendocrinol"},{"key":"1250_CR22","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1210\/jc.2009-1191","volume":"95","author":"G Raverot","year":"2010","unstructured":"Raverot G, Wierinckx A, Dantony E et al (2010) Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 95:1708\u20131716. https:\/\/doi.org\/10.1210\/jc.2009-1191","journal-title":"J Clin Endocrinol Metab"},{"key":"1250_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR et al (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"key":"1250_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s12020-015-0791-7","volume":"52","author":"E Espinosa","year":"2016","unstructured":"Espinosa E, Sosa E, Mendoza V et al (2016) Giant prolactinomas: are they really different from ordinary macroprolactinomas? Endocrine 52:652\u2013659. https:\/\/doi.org\/10.1007\/s12020-015-0791-7","journal-title":"Endocrine"},{"key":"1250_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/EJE-11-0304","volume":"165","author":"MA Tichomirowa","year":"2011","unstructured":"Tichomirowa MA, Barlier A, Daly AF et al (2011) High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol 165:509\u2013515. https:\/\/doi.org\/10.1530\/EJE-11-0304","journal-title":"Eur J Endocrinol"},{"key":"1250_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fendo.2019.00837","volume":"10","author":"MFM van den Broek","year":"2019","unstructured":"van den Broek MFM, van Nesselrooij BPM, Verrijn Stuart AA et al (2019) Clinical relevance of genetic analysis in patients with pituitary adenomas: a systematic review. Front Endocrinol (Lausanne) 10:837. https:\/\/doi.org\/10.3389\/fendo.2019.00837","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1250_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1530\/EJE-21-0075","volume":"185","author":"I Mart\u00ednez de LaPiscina","year":"2021","unstructured":"Mart\u00ednez de LaPiscina I, Portillo Najera N, Rica I et al (2021) Clinical and genetic characteristics in patients under 30\u00a0years with sporadic pituitary adenomas. Eur J Endocrinol 185:485\u2013496. https:\/\/doi.org\/10.1530\/EJE-21-0075","journal-title":"Eur J Endocrinol"},{"key":"1250_CR28","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1210\/jc.2009-2556","volume":"95","author":"AF Daly","year":"2010","unstructured":"Daly AF, Tichomirowa MA, Petrossians P et al (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95:E373-383. https:\/\/doi.org\/10.1210\/jc.2009-2556","journal-title":"J Clin Endocrinol Metab"},{"key":"1250_CR29","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1210\/JC.2015-2015","volume":"100","author":"JM de Laat","year":"2015","unstructured":"de Laat JM, Dekkers OM, Pieterman CRC et al (2015) Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 study group (DMSG). J Clin Endocrinol Metab 100:3288\u20133296. https:\/\/doi.org\/10.1210\/JC.2015-2015","journal-title":"J Clin Endocrinol Metab"},{"key":"1250_CR30","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1210\/clinem\/dgaa650","volume":"105","author":"M Sehemby","year":"2020","unstructured":"Sehemby M, Lila AR, Sarathi V et al (2020) Predictors of chronic LH-testosterone axis suppression in male macroprolactinomas with normoprolactinemia on cabergoline. J Clin Endocrinol Metab 105:650. https:\/\/doi.org\/10.1210\/clinem\/dgaa650","journal-title":"J Clin Endocrinol Metab"},{"key":"1250_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJM197810192991602","volume":"299","author":"JN Carter","year":"1978","unstructured":"Carter JN, Tyson JE, Tolis G et al (1978) Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med 299:847\u2013852. https:\/\/doi.org\/10.1056\/NEJM197810192991602","journal-title":"N Engl J Med"},{"key":"1250_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2015.36","volume":"11","author":"V Bernard","year":"2015","unstructured":"Bernard V, Young J, Chanson P, Binart N (2015) New insights in prolactin: pathological implications. Nat Rev Endocrinol 11:265\u2013275. https:\/\/doi.org\/10.1038\/nrendo.2015.36","journal-title":"Nat Rev Endocrinol"},{"key":"1250_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/andr.262","volume":"2","author":"G Rastrelli","year":"2014","unstructured":"Rastrelli G, Corona G, Mannucci E, Maggi M (2014) Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology 2:794\u2013808. https:\/\/doi.org\/10.1111\/andr.262","journal-title":"Andrology"},{"key":"1250_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11102-020-01111-6","volume":"24","author":"R Shah","year":"2021","unstructured":"Shah R, Patil V, Sarathi V et al (2021) Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism. Pituitary 24:326\u2013333. https:\/\/doi.org\/10.1007\/s11102-020-01111-6","journal-title":"Pituitary"},{"key":"1250_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4158\/EP-2018-0392","volume":"25","author":"O Hamidi","year":"2019","unstructured":"Hamidi O, Van Gompel J, Gruber L et al (2019) Management and outcomes of giant prolactinoma: a series of 71 patients. Endocr Pract 25:340\u2013352. https:\/\/doi.org\/10.4158\/EP-2018-0392","journal-title":"Endocr Pract"},{"key":"1250_CR36","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1210\/jc.2007-0373","volume":"92","author":"SGI Suliman","year":"2007","unstructured":"Suliman SGI, Gurlek A, Byrne JV et al (2007) Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features. J Clin Endocrinol Metab 92:3829\u20133835. https:\/\/doi.org\/10.1210\/jc.2007-0373","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01250-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01250-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T21:36:31Z","timestamp":1668893791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01250-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1250"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01250-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"28 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no conflict of interest could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was started after approval by the Institutional Ethics Committee (EC\/OA-142\/2020), Seth GS Medical College and KEM Hospital. Individual patient identity was kept confidential and coded prior to analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Considering retrospective nature of analysis, waiver for consent was obtained from the Ethics committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of participate"}},{"value":"All the the co-authors have consented for publication of the study results.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}